Chris Cardon

Chris Cardon

Company: Ziphius Vaccines

Job title: CEO


Advancing CMC Strategies for Self-Amplifying RNA to Achieve a Transition from Discovery through to Clinic 11:00 am

How to optimise CMC methods for self-amplifying RNA whilst de-risking failures Examining platform requirements for a scalable production process to meeting the needs at each phase Maximising volume and speed to ensure future clinical successRead more

day: Day One Track B AM

CEO & Future Leaders’ Fireside Chat 11:00 am

With the next wave of mRNA medicines approaching, and companies who were involved pre- pandemic now utilising validated platforms to develop new therapeutics and vaccines, this leads to the inevitable question: What comes next? We now need to realise the opportunities of such mRNA- based therapeutic applications, as we hear from the leaders of the…Read more

day: Pre-Conference Day AM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.